Literature DB >> 17934032

[Early detection and treatment of panic disorder with or without agoraphobia: update].

Guillaume Foldes-Busque1, André Marchand, Pierre Landry.   

Abstract

OBJECTIVE: To describe for family physicians screening, diagnosis, and treatment of panic disorder with or without agoraphobia (PD/A). QUALITY OF EVIDENCE: Articles were identified through PsycLIT, PsyINFO, and MEDLINE (1985 to 2006) using the terms panic disorder, psychotherapy, psychosocial treatment, treatment, and pharmacotherapy. Recommendations on treatment choices and guidelines are based on data from high-quality studies only. Information about assessment and diagnosis of PD/A is supported by the most recent epidemiologic studies, as well as expert consensus and opinion. MAIN MESSAGE: Panic disorder with or without agoraphobia is a psychiatric disease frequently encountered in primary care. It appears to be underdiagnosed and undertreated in this medical setting. Early successful screening requires a focus on unexplained symptoms and specific questions aimed at identifying panic attacks and their meaning for patients. The treatment of choice for PD/A is cognitive-behavioral therapy administered by a specialized psychologist or psychiatrist. When such therapy is hard to come by or unavailable, family physicians can prescribe drug therapy.
CONCLUSION: Family physicians can contribute greatly to early detection and treatment of PD/A.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17934032      PMCID: PMC2231433     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  37 in total

1.  Does the addition of cognitive behavioral therapy improve panic disorder treatment outcome relative to medication alone in the primary-care setting?

Authors:  Michelle G Craske; Daniela Golinelli; Murray B Stein; Peter Roy-Byrne; Alexander Bystritsky; Cathy Sherbourne
Journal:  Psychol Med       Date:  2005-11       Impact factor: 7.723

2.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

3.  Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial.

Authors:  D H Barlow; J M Gorman; M K Shear; S W Woods
Journal:  JAMA       Date:  2000-05-17       Impact factor: 56.272

4.  Empirically supported treatments for panic disorder: costs, benefits, and stepped care.

Authors:  M W Otto; M H Pollack; K M Maki
Journal:  J Consult Clin Psychol       Date:  2000-08

Review 5.  Paroxetine in panic disorder: clinical management and long-term follow-up.

Authors:  Pinhas N Dannon; Katherine Lowengrub; I Iancu; Moshe Kotler
Journal:  Expert Rev Neurother       Date:  2004-03       Impact factor: 4.618

6.  The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Robert Jin; Ayelet Meron Ruscio; Katherine Shear; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2006-04

Review 7.  Treatment of anxiety disorders with venlafaxine XR.

Authors:  Michael E Thase
Journal:  Expert Rev Neurother       Date:  2006-03       Impact factor: 4.618

8.  Medical utilisation and costs in panic disorder: a comparison with social phobia.

Authors:  C S Rees; J C Richards; L M Smith
Journal:  J Anxiety Disord       Date:  1998 Sep-Oct

9.  Knowledge About Recommended Treatment and Management of Major Depressive Disorder, Panic Disorder, and Generalized Anxiety Disorder Among Family Physicians.

Authors:  David Katerndahl; Robert L. Ferrer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

10.  Detecting panic disorder in medical and psychosomatic outpatients: comparative validation of the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire, a screening question, and physicians' diagnosis.

Authors:  Bernd Löwe; Kerstin Gräfe; Stephan Zipfel; Robert L Spitzer; Christoph Herrmann-Lingen; Steffen Witte; Wolfgang Herzog
Journal:  J Psychosom Res       Date:  2003-12       Impact factor: 3.006

View more
  1 in total

1.  A prospective cohort study to refine and validate the Panic Screening Score for identifying panic attacks associated with unexplained chest pain in the emergency department.

Authors:  Guillaume Foldes-Busque; Isabelle Denis; Julien Poitras; Richard P Fleet; Patrick Archambault; Clermont E Dionne
Journal:  BMJ Open       Date:  2013-10-25       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.